{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:39:42Z","timestamp":1771328382487,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12185-014-1585-z","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T11:17:41Z","timestamp":1399375061000},"page":"743-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols"],"prefix":"10.1007","volume":"99","author":[{"name":"Lymphoma Committee, Japanese Association of Childhood Leukemia Study","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Akazai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Yamato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Hashii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"1585_CR1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mpo.2950200204","volume":"20","author":"C Patte","year":"1992","unstructured":"Patte C, Kalifa C, Flamant F, Hartmann O, Brugi\u00e8res L, Valteau-Couanet D, Bayle C, Caillaud JM, Lemerle J. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol. 1992;20:105\u201313.","journal-title":"Med Pediatr Oncol."},{"key":"1585_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.2005.02.2707","volume":"24","author":"B Burkhardt","year":"2006","unstructured":"Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. J Clin Oncol. 2006;24:491\u20139.","journal-title":"J Clin Oncol."},{"key":"1585_CR3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ejca.2008.02.011","volume":"44","author":"A Uyttebroeck","year":"2008","unstructured":"Uyttebroeck A, Suciu S, Laureys G, Robert A, Pacquement H, Ferster A, Marguerite G, Mazingue F, Renard M, Lutz P, Rialland X, Mechinaud F, Cav\u00e9 H, Baila L, Bertrand Y. Children\u2019s Leukaemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC). Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: long term results of the EORTC CLG 58881 trial. Eur J Cancer. 2008;44:840\u20136.","journal-title":"Eur J Cancer."},{"key":"1585_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2141.2008.07320.x","volume":"143","author":"M Abromowitch","year":"2008","unstructured":"Abromowitch M, Sposto R, Perkins S, Zwick D, Siegel S, Finlay J, Cairo MS, Children\u2019s Oncology Group. Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children\u2019s Oncology Group. Br J Haematol. 2008;143:261\u20137.","journal-title":"Br J Haematol."},{"key":"1585_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.22162","volume":"53","author":"M Pillon","year":"2009","unstructured":"Pillon M, Piglione M, Garaventa A, Conter V, Giuliano M, Arcamone G, Mura R, Cellini M, D\u2019Amore ES, Varotto S, Mussolin L, Rosolen A, AIEOP-NHL Committee. Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer. 2009;53:953\u20139.","journal-title":"Pediatr Blood Cancer."},{"key":"1585_CR6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/leu.2008.400","volume":"23","author":"JT Sandlund","year":"2009","unstructured":"Sandlund JT, Pui CH, Zhou Y, Behm FG, Onciu M, Razzouk BI, Hijiya N, Campana D, Hudson MM, Ribeiro RC. Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study. Leukemia. 2009;23:1127\u201330.","journal-title":"Leukemia."},{"key":"1585_CR7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2010-06-292615","volume":"118","author":"BL Asselin","year":"2011","unstructured":"Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, Lipshultz SE, Camitta BM. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children\u2019s Oncology Group (POG 9404). Blood. 2011;118:874\u201383.","journal-title":"Blood."},{"key":"1585_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12185-013-1364-2","volume":"98","author":"K Horibe","year":"2013","unstructured":"Horibe K, Saito AM, Takimoto T, Tsuchida M, Manabe A, Shima M, Ohara A, Mizutani S. Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006\u20132010): based on registry data from the Japanese Society of Pediatric Hematology. Int J Hematol. 2013;98:74\u201388.","journal-title":"Int J Hematol."},{"key":"1585_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood.V108.11.211.211","volume":"108","author":"M Oda","year":"2006","unstructured":"Oda M, Yumura-Yagi K, Hara J, Nishimura S, Tawa A, Komada Y, Kudo T, Yoshida M, Kobayashi R, Takimoto T, Nakagawa A, Horibe K, The Japan Association of Childhood Leukemia Study(JACLS). Mediastinal mass with bone marrow involvement is a favorable factor for childhood T-lymphoid malignancy in Japan. Blood. 2006;108:211.","journal-title":"Blood."},{"key":"1585_CR10","unstructured":"Hasegawa D, Oda M, Yumura-Yagi K, Hara J, Nishimura S, Tawa A, Sato A, Kawasaki H, Hori H, Yoshida M, Kobayashi R, Takimoto T, Nakazawa A, Kobayashi M, Suzuki N, Inoue M, Hashii Y, Kato K, Kounami S, Saito A, Komada Y, Kudo T, Nakahata T, Horibe K, the Japan Association of Childhood Leukemia Study (JACLS). Intensive high dose asparaginase-containing block therapy improves the survival of childhood T cell acute lymphoblastic leukemia: A report from the Japan Association of Childhood Leukemia Study Group. Pediatr Blood Cancer submitted."},{"key":"1585_CR11","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332\u20139.","journal-title":"Semin Oncol."},{"issue":"84","key":"1585_CR12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"1","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;1(84):1361\u201392.","journal-title":"Blood."},{"key":"1585_CR13","first-page":"176","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"M Borowitz","year":"2008","unstructured":"Borowitz M, Chan J. T lymphoblastic leukemia\/lymphoma. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thiele J, Vardiman J, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008. p. 176\u20138."},{"key":"1585_CR14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood.V57.6.1105.1105","volume":"57","author":"A Bernard","year":"1981","unstructured":"Bernard A, Boumsell L, Reinherz EL, Nadler LM, Ritz J, Coppin H, Richard Y, Valensi F, Dausset J, Flandrin G, Lemerle J, Schlossman SF. Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood. 1981;57:1105\u201310.","journal-title":"Blood."},{"key":"1585_CR15","first-page":"4486","volume":"43","author":"J Cossman","year":"1983","unstructured":"Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res. 1983;43:4486\u201390.","journal-title":"Cancer Res."},{"key":"1585_CR16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood.V67.2.474.474","volume":"67","author":"LM Weiss","year":"1986","unstructured":"Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood. 1986;67:474\u20138.","journal-title":"Blood."},{"key":"1585_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0889-8588(18)30642-7","volume":"1","author":"IT Magrath","year":"1987","unstructured":"Magrath IT. Malignant non-Hodgkin\u2019s lymphomas in children. Hematol Oncol Clin North Am. 1987;1:577\u2013602.","journal-title":"Hematol Oncol Clin North Am."},{"key":"1585_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/1097-0142(19870715)60:2<183::AID-CNCR2820600211>3.0.CO;2-0","volume":"60","author":"K Sheibani","year":"1987","unstructured":"Sheibani K, Nathwani BN, Winberg CD, Burke JS, Swartz WG, Blayney D, van de Velde S, Hill LR, Rappaport H. Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer. 1987;60:183\u201390.","journal-title":"Cancer."},{"key":"1585_CR19","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.V72.6.1891.1891","volume":"72","author":"WM Crist","year":"1988","unstructured":"Crist WM, Shuster JJ, Falletta J, Pullen DJ, Berard CW, Vietti TJ, Alvarado CS, Roper MA, Prasthofer E, Grossi CE. Clinical features and outcome in childhood T-cell leukemia-lymphoma according to stage of thymocyte differentiation: a Pediatric Oncology Group Study. Blood. 1988;72:1891\u20137.","journal-title":"Blood."},{"key":"1585_CR20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/07357909609012148","volume":"14","author":"AS Freedman","year":"1996","unstructured":"Freedman AS. Cell surface antigens in leukemias and lymphomas. Cancer Invest. 1996;14:252\u201376.","journal-title":"Cancer Invest."},{"key":"1585_CR21","first-page":"575","volume-title":"Non-Hodgkin\u2019s Lymphoma","author":"J Sandlund","year":"2003","unstructured":"Sandlund J, Marcus K, Behm F. Management of lymphoma in children. In: Mauch P, Armitage J, Coiffier B, Dalla-Favera R, Harris N, editors. Non-Hodgkin\u2019s Lymphoma. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 575\u201397."},{"key":"1585_CR22","first-page":"745","volume":"2","author":"Y Kaneko","year":"1988","unstructured":"Kaneko Y, Frizzera G, Maseki N, Sakurai M, Komada Y, Hiyoshi Y, Nakadate H, Takeda T. A novel translocation, t(9;17)(q34;q23), in aggressive childhood lymphoblastic lymphoma. Leukemia. 1988;2:745\u20138.","journal-title":"Leukemia."},{"key":"1585_CR23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/1097-0142(19920801)70:3<714::AID-CNCR2820700329>3.0.CO;2-Z","volume":"70","author":"T Shikano","year":"1992","unstructured":"Shikano T, Ishikawa Y, Naito H, Kobayashi R, Nakadate H, Hatae Y, Takeda T. Cytogenetic characteristics of childhood non-Hodgkin lymphoma. Cancer. 1992;70:714\u20139.","journal-title":"Cancer."},{"key":"1585_CR24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2141.2009.08006.x","volume":"149","author":"B Burkhardt","year":"2010","unstructured":"Burkhardt B. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol. 2010;149:653\u201368.","journal-title":"Br J Haematol."},{"key":"1585_CR25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2011.08788.x","volume":"154","author":"M Sekimizu","year":"2011","unstructured":"Sekimizu M, Sunami S, Nakazawa A, Hayashi Y, Okimoto Y, Saito AM, Horibe K, Tsurusawa M, Mori T. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia\/Lymphoma Study Group (JPLSG) and review of the literature. Br J Haematol. 2011;154:612\u20137.","journal-title":"Br J Haematol."},{"key":"1585_CR26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10428190701824551","volume":"49","author":"B Burkhardt","year":"2008","unstructured":"Burkhardt B, Moericke A, Klapper W, Greene F, Salzburg J, Damm-Welk C, Zimmermann M, Strauch K, Ludwig WD, Schrappe M, Reiter A. Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact. Leuk Lymphoma. 2008;49:451\u201361.","journal-title":"Leuk Lymphoma."},{"key":"1585_CR27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.2009.07607.x","volume":"145","author":"M Park","year":"2009","unstructured":"Park M, Taki T, Oda M, Watanabe T, Yagi YK, Kobayashi R, Suzuki N, Hara J, Horibe K, Hayashi Y. FBW7 and NOTCH1 mutations in childhood T-cell acute lymphoblastic leukemia and T cell non-Hodgkin\u2019s lymphoma. Br J Hematol. 2009;145:198\u2013206.","journal-title":"Br J Hematol."},{"issue":"121","key":"1585_CR28","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2012-12-474148","volume":"18","author":"BR Bonn","year":"2013","unstructured":"Bonn BR, Rohde M, Zimmermann M, Krieger D, Oschlies I, Niggli F, Wrobel G, Attarbaschi A, Escherich G, Klapper W, Reiter A, Burkhardt B. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood. 2013;18(121):3153\u201360.","journal-title":"Blood."},{"key":"1585_CR29","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, Schirg E, Henze G, Schellong G, Gadner H, Riehm H. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416\u201321.","journal-title":"Blood."},{"key":"1585_CR30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10147-008-0771-5","volume":"13","author":"XF Sun","year":"2008","unstructured":"Sun XF, Xia ZJ, Zhen ZJ, Xiang XJ, Xia Y, Ling JY, Liu DG, Huang HQ, Zhen L, Luo WB, Lin H, Guan ZZ. Intensive chemotherapy improved treatment outcome for Chinese children and adolescents with lymphoblastic lymphoma. Int J Clin Oncol. 2008;13:436\u201341.","journal-title":"Int J Clin Oncol."},{"key":"1585_CR31","first-page":"865","volume":"46","author":"S Sunami","year":"2006","unstructured":"Sunami S, Mori T, Kikuchi A, Kumagai M, Okimoto Y, Fujimoto J, Tsuchida M. Outcome of children with advanced T-cell lymphoblastic lymphoma treated by ALL-type regimen containing high-dose cytrabine: results of the Tokyo Children\u2019s Cancer Study Group Study NHL T9604. Pediatr Blood Cancer. 2006;46:865.","journal-title":"Pediatr Blood Cancer."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1585-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1585-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1585-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T02:10:33Z","timestamp":1597803033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1585-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1585-z","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]}}}